115 related articles for article (PubMed ID: 25821790)
1. A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial age.
Janić M; Lunder M; Šabovič M
Biomed Res Int; 2015; 2015():235709. PubMed ID: 25821790
[TBL] [Abstract][Full Text] [Related]
2. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.
Lunder M; Janić M; Jug B; Sabovič M
Eur J Intern Med; 2012 Apr; 23(3):261-6. PubMed ID: 22385885
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Fluvastatin and Valsartan Rejuvenate the Arterial Wall Through Telomerase Activity Increase in Middle-Aged Men.
Janić M; Lunder M; Cerkovnik P; Prosenc Zmrzljak U; Novaković S; Šabovič M
Rejuvenation Res; 2016 Apr; 19(2):115-9. PubMed ID: 26214555
[TBL] [Abstract][Full Text] [Related]
4. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
Boncelj Svetek M; Eržen B; Kanc K; Šabovič M
J Diabetes Complications; 2017 Mar; 31(3):544-550. PubMed ID: 28012835
[TBL] [Abstract][Full Text] [Related]
5. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
Savić V; Eržen B; Janić M; Lunder M; Boncelj M; Kanc K; Janež A; Šabović M
Diab Vasc Dis Res; 2013 Sep; 10(5):420-5. PubMed ID: 23811602
[TBL] [Abstract][Full Text] [Related]
6. A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.
Janić M; Lunder M; Prezelj M; Šabovič M
J Cardiopulm Rehabil Prev; 2014; 34(3):208-12. PubMed ID: 24263076
[TBL] [Abstract][Full Text] [Related]
7. Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus.
Lunder M; Janić M; Savić V; Janež A; Kanc K; Šabovič M
Diabetes Res Clin Pract; 2017 May; 127():181-186. PubMed ID: 28384560
[TBL] [Abstract][Full Text] [Related]
8. Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
Janić M; Lunder M; France Štiglic A; Jerin A; Skitek M; Černe D; Marc J; Drevenšek G; Šabovič M
Vascul Pharmacol; 2017 Dec; 99():45-52. PubMed ID: 28951255
[TBL] [Abstract][Full Text] [Related]
9. Improvement of arterial wall phenotype in subjects at moderate cardiovascular risk induced by very low-dose fluvastatin/valsartan combination: a pilot study.
Turk Veselič M; Žorž N; Eržen B; Škerl P; Novaković S; Janić M; Šabovič M
Int Angiol; 2018 Oct; 37(5):356-364. PubMed ID: 29952159
[TBL] [Abstract][Full Text] [Related]
10. Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males--a pilot study.
Lunder M; Janić M; Habjan S; Sabovič M
Atherosclerosis; 2011 Apr; 215(2):446-51. PubMed ID: 21300350
[TBL] [Abstract][Full Text] [Related]
11. A new anti-ageing strategy focused on prevention of arterial ageing in the middle-aged population.
Janić M; Lunder M; Sabovič M
Med Hypotheses; 2013 Jun; 80(6):837-40. PubMed ID: 23587479
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
13. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
Kansui Y; Fujii K; Goto K; Oniki H; Iida M
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
[TBL] [Abstract][Full Text] [Related]
14. Long-term improvement of arterial wall characteristics in patients with diabetes mellitus type 1 using cyclic, intermittent treatment with a low-dose fluvastatin and valsartan combination.
Savić V; Janić M; Lunder M; Kanc K; Janež A; Eržen B; Šabovič M
Exp Ther Med; 2015 Sep; 10(3):1207-1211. PubMed ID: 26622466
[TBL] [Abstract][Full Text] [Related]
15. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
16. Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat "Aging-Related Disorders".
Janić M; Lunder M; Novaković S; Škerl P; Šabovič M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013989
[TBL] [Abstract][Full Text] [Related]
17. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
18. The low-dose atorvastatin and valsartan combination effectively protects the arterial wall from atherogenic diet-induced impairment in the guinea pig.
Janić M; Lunder M; Zupan J; Černe D; Marc J; Drevenšek G; Šabovič M
Eur J Pharmacol; 2014 Nov; 743():31-6. PubMed ID: 25261034
[TBL] [Abstract][Full Text] [Related]
19. Lipid-independent effects of an estrogen-statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor--I in human endothelial cell cultures.
Seeger H; Wallwiener D; Mueck AO
Climacteric; 2001 Sep; 4(3):209-14. PubMed ID: 11588944
[TBL] [Abstract][Full Text] [Related]
20. Does fluvastatin really have an antioxidant effect in humans?
Nagase S; Hirayama A; Ueda A; Hirayama K; Terao J; Koyama A
Kidney Int; 2005 Sep; 68(3):1373-4. PubMed ID: 16105083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
